Drug
Tolterodine
Tolterodine: highest development phase Phase 3, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| tolterodine extended release capsule NCT00139724 | Phase 3 | Urinary Incontinence |
Latest
No recent events.
Follow Tolterodine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.